• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

87
15
12
11
11

COUNTRY

11
3
3
3
2

CATEGORIES

  • 34
  • 32
  • 29
  • 12
  • 12
  • 10
  • 6
  • 6
  • 6
  • 3
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL…

PRICE

6
8
21
133

PUBLISHED

0
2
28
133

PRODUCT TYPE

129
3
1

Search "Breast Cancer Drug Futures 2010" returned 133 results.

PRODUCT TITLE

Breast Cancer Therapies Markets

Breast cancer therapies are entering a new era as game-changers emerge for each of the major breast cancer patient populations New market entrants must possess drug profiles and a savvy clinical development...

November 2012
FROM

Oncology Therapeutics Market in India to 2018 - Introduction of Market-Based Pricing to Fuel Price Wars and Intense Competition Among Domestic and Multinational Players

GBI Research, the leading business intelligence provider, has released its latest research, ""Oncology Therapeutics Market in India to 2018 - Introduction of Market-Based Pricing to Fuel Price Wars...

April 2013
FROM

Molecular Diagnostics in Cancer Testing

Molecular diagnostics is a rapidly-advancing area of research and medicine, with new technologies and applications being continually added The technologies that come under the umbrella of molecular...

November 2013
FROM

Therapeutic Cancer Vaccines Market to 2019 - Pipeline Indicates Safer Treatments and Extended Patient Survival, though High Prices May Limit Uptake

GBI Research, the leading business intelligence provider, has released its latest research “Therapeutic Cancer Vaccines Market to 2019 - Pipeline Indicates Safer Treatments and Extended Patient Survival,...

March 2013
FROM

Cytotoxic Therapies Market to 2017 - Launch of Next Generation Camptothecin Analogues Will Help Offset Revenue Loss due to Generic Erosion

GBI Research, the leading business intelligence provider, has released its latest research, “Cytotoxic Therapies Market to 2017 - Launch of Next Generation Camptothecin Analogues Will Help Offset Revenue...

April 2012
FROM
Cancer Therapies - Global Strategic Business Report Cancer Therapies - Global Strategic Business Report - Product Thumbnail Image

Cancer Therapies - Global Strategic Business Report

This report analyzes the worldwide markets for Cancer Therapies in US$ Million by the following Product Segments: Immunotherapy, Targeted Therapy, Hormonal Therapy, and Chemotherapy The report provides...

October 2011
FROM

Oncology Market in China to 2017 - Better Access to Cancer Therapies for the Rising Cancer Population through Healthcare Reforms Drives the Market

Oncology Market in China to 2017 - Better Access to Cancer Therapies for the Rising Cancer Population through Healthcare Reforms Drives the Market Summary GBI Research, the leading business intelligence...

January 2011
FROM

Cancer Diagnostic Testing World Markets

Cancer testing is one of the most important growth opportunities for the next three to five years in the diagnostics segment The National Cancer Institute estimates that about ten million Americans...

May 2013
FROM
The Cancer Market Outlook to 2016 The Cancer Market Outlook to 2016 - Product Thumbnail Image

The Cancer Market Outlook to 2016

The global cancer market is becoming increasingly competitive, with two therapeutic classes, namely antineoplastics and cytostatic hormonal treatments, dominating this sector This report presents leading...

June 2011
FROM

Cancer Bundle

The Cancer Bundle offers a 15% discount off the total transaction price for the following reports being purchased simultaneously: - Biomarker Technology Platforms for Cancer Diagnoses and Therapies...

May 2012
FROM
Pipeline Insight: Cancer Overview- Breast and Gynecological Cancers - Promising agents emerge for BRCA positive patients Pipeline Insight: Cancer Overview- Breast and Gynecological Cancers - Promising agents emerge for BRCA positive patients - Product Thumbnail Image

Pipeline Insight: Cancer Overview- Breast and Gynecological Cancers - Promising agents emerge for BRCA positive patients

The three tumor types covered in this report are set to account for just over 585,000 new cancer cases in 2010 with forecasts of over 656,000 new cases in 2019. Collectively the drugs profiled in this...

January 2011
FROM

Biomarker Technology Platforms for Cancer Diagnoses and Therapies

Until superior therapeutic treatments are developed to prevent, treat and cure cancer, the best means of reducing mortality and morbidity in a disease this complex is early detection and diagnosis In...

September 2011
FROM

Personalized Medicine - A Strategic Analysis of Industry Trends, Technologies, Participants and Environment

“Personalized Medicine- A Strategic Analysis of Industry Trends, Technologies, Participants, and Environment” provides you with a comprehensive account of the market size, segmentation, key players,...

May 2013
FROM

Cancer Monoclonal Antibodies Market Forecast to 2017

Cancer, one of the leading causes of death worldwide, affected approximately 13 Million people in 2012 and this figure is expected to grow to 17 Million by 2020 The dramatic increase in the size of...

August 2013
FROM

Pharmaceutical Pricing and Reimbursement in Oncology - Payer Pressure to Justify Premium Pricing of Novel Agents, Pushing Companies to Risk-Sharing Modalities

Pharmaceutical Pricing and Reimbursement in Oncology - Payer Pressure to Justify Premium Pricing of Novel Agents, Pushing Companies to Risk-Sharing Modalities Summary GBI Research, leading business...

July 2012
FROM

Monoclonal Antibodies Market to 2017 - Multiple Indication Approvals and the Potential for MAbs in Oncology and Autoimmune Diseases are Re-Shaping the Market

GBI Research, the leading business intelligence provider, has released its latest research “Monoclonal Antibodies Market to 2017 - Multiple Indication Approvals and the Potential for MAbs in Oncology...

December 2011
FROM
Cancer Therapeutics 2006: Market Dynamics and R&D Trends Cancer Therapeutics 2006: Market Dynamics and R&D Trends - Product Thumbnail Image

Cancer Therapeutics 2006: Market Dynamics and R&D Trends

Together, the four major cancer markets, which include colorectal, prostate, lung and breast cancer were valued at well over $16 billion in 2005, which was an increase of 14 percent in value since 2004....

December 2005
FROM
Nanotechnology for Drug Delivery - Global Market for Nanocarriers Nanotechnology for Drug Delivery - Global Market for Nanocarriers - Product Thumbnail Image

Nanotechnology for Drug Delivery - Global Market for Nanocarriers

Nanocarriers will account for 40% of a $136 billion nanotechnology-enabled drug delivery market by 2021 We forecast the total market size in 2021 to be US$136 billion, with a 60/40 split between nanocrystals...

February 2012
FROM
Implantable Drug Delivery Devices (Contraceptives, Drug Infusion Pumps, Intraocular Implants, Drug Eluting, Bio-Absorbable Stents, Biodegradable) Market - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 - 2018 Implantable Drug Delivery Devices (Contraceptives, Drug Infusion Pumps, Intraocular Implants, Drug Eluting, Bio-Absorbable Stents, Biodegradable) Market - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 - 2018 - Product Thumbnail Image

Implantable Drug Delivery Devices (Contraceptives, Drug Infusion Pumps, Intraocular Implants, Drug Eluting, Bio-Absorbable Stents, Biodegradable) Market - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 - 2018

The global implantable drug delivery devices hold a competitive edge over other drugs and devices owing to the fact that they are implanted at targeted sites and so deliver unaltered amounts of drugs...

March 2013
FROM
2013 France Procedure Volumes Database 2013 France Procedure Volumes Database - Product Thumbnail Image

2013 France Procedure Volumes Database

This in-depth procedure volumes database quantifies current and forecast (2010-2017) procedure volumes across a spectrum of medical segments in some of the most promising and emerging markets Extensive...

May 2013
FROM
Loading Indicator